Intended for healthcare professionals


Comparative accuracy: assessing new tests against existing diagnostic pathways

BMJ 2006; 332 doi: (Published 08 June 2006) Cite this as: BMJ 2006;332:1368

In this Analysis and Comment article by Patrick M Bossuyt and colleagues (BMJ 2006;332:1089-92, 6 May), the authors made a small error in table 2 that does not affect the ideas they discussed. Among the proposed add-on diagnostic tests, they listed neuroimaging with 123I for Parkinson's disease. The enigmatic and potentially confusing 123I should have been (123I)β-CIT, in other words, (123I)β-carboxymethoxy-3-β-(4-iodophenyl)-tropane.


View Abstract